Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Retained Earnings: 2009-2025

Historic Retained Earnings for Corcept Therapeutics (CORT) over the last 13 years, with Sep 2025 value amounting to $619.1 million.

  • Corcept Therapeutics' Retained Earnings rose 20.68% to $619.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $619.1 million, marking a year-over-year increase of 20.68%. This contributed to the annual value of $543.7 million for FY2024, which is 35.08% up from last year.
  • Latest data reveals that Corcept Therapeutics reported Retained Earnings of $619.1 million as of Q3 2025, which was up 3.28% from $599.4 million recorded in Q2 2025.
  • In the past 5 years, Corcept Therapeutics' Retained Earnings registered a high of $619.1 million during Q3 2025, and its lowest value of $105.9 million during Q1 2021.
  • Moreover, its 3-year median value for Retained Earnings was $465.8 million (2024), whereas its average is $469.2 million.
  • Data for Corcept Therapeutics' Retained Earnings shows a peak YoY surged of 1,527.05% (in 2021) over the last 5 years.
  • Corcept Therapeutics' Retained Earnings (Quarterly) stood at $195.0 million in 2021, then soared by 52.02% to $296.4 million in 2022, then surged by 35.81% to $402.5 million in 2023, then skyrocketed by 35.08% to $543.7 million in 2024, then rose by 20.68% to $619.1 million in 2025.
  • Its Retained Earnings was $619.1 million in Q3 2025, compared to $599.4 million in Q2 2025 and $564.3 million in Q1 2025.